Furthermore, since CXCL10 can modulate the physical tumor barrier, treatment with TNFα can increase vascular permeability, facilitating the extravasation of NP-encapsulated chemotherapy into the tumor [205], underscoring the versatility of this approach in combination with chemokine-based therapies. The gene discussed is CXCL10; the disease is neoplasm.